2006 Lilly Oncology On Canvas(SM) International Art Competition Receives More Than 2,000 Entries
September 28 2006 - 2:00AM
PR Newswire (US)
Free Public Exhibitions Planned in London and New York
INDIANAPOLIS, Sept. 28 /PRNewswire/ -- If a picture paints a
thousand words, just imagine what two thousand images can say. Eli
Lilly and Company is proud to be the recipient of more than 2,000
works of art from 43 countries for the 2006 Lilly Oncology on
Canvas(SM): Expressions of a Cancer Journey International Art
Competition and Exhibition. If the artwork were laid end to end in
a straight line, it would span the length of 14 rugby fields. Lilly
Oncology on Canvas invited people from all over the world to put
their feelings about cancer on canvas and in narrative. People
diagnosed with any type of cancer, their families and friends,
cancer advocates, health care providers, artists and art students
were all eligible. This is the second Lilly Oncology on Canvas
competition. The competition was launched by Lilly in 2004 to help
people affected by cancer deal with the emotional side effects of
the disease, an important part of the healing process. The 2004
collection of art has since toured the world. The 2006 Lilly
Oncology on Canvas competition represents nearly a 500 percent
increase in entries over the inaugural competition. In 2004, more
than 400 entries were received including 108 entries from Mexico,
59 from the U.S. and 45 entries from Hungary. The 2006 competition
yielded more than 2,000 entries, including 400 entries from Mexico,
250 from Hungary and 130 entries from Venezuela. "We are proud of
the substantial increase in entries because it clearly reflects the
value of this program," said John C. Lechleiter, Ph.D., president
and chief operating officer of Lilly. "In addition to our
relentless efforts to discover innovative cancer treatments, Lilly
is dedicated to helping treat the whole patient and providing
inspiration for all affected by this disease." The competition now
moves on to the judging phase. Winners will be selected from six
categories (watercolour, oil, pastel, photography, acrylic, other)
and will be chosen by an independent panel of judges, comprised of
cancer survivors, oncologists, journalists, cancer advocates and
artists (see below). Winners will be awarded monetary prizes for
the cancer charities of their choice. The Lilly Oncology on Canvas
winners will be announced to the media at two upcoming grand
finales in London and New York City, 3 November and 5 December,
respectively. The London event will be graced with the presence of
HRH The Duke of Gloucester (first cousin to HM Queen Elizabeth II).
The New York event will include a live musical performance by a
special guest. After the finale events, the exhibitions will be
open to the public free of charge as follows: * Royal College of
Art, London, 3 November, 1:00 p.m.-5:30 p.m., 4-6 November, 10:00
a.m.-5:30 p.m. * Metropolitan Pavilion, The Level, New York City,
6-8 December, 10:00 a.m.-7:00 p.m. The 2004 Lilly Oncology on
Canvas exhibition will continue to tour the world at hospitals,
cancer centers and art galleries. The 2006 entries will tour
throughout 2007 and 2008. The 2006 Lilly Oncology on Canvas Judging
Panel (in alphabetical order): Catalina Aroch, 2004 Global Winner,
Lilly Oncology on Canvas Anita Chernewski, U.S. Art Director, Lilly
Oncology on Canvas (Ex-Officio) Michael Cullen, M.D., Consultant
Medical Oncologist, Queen Elizabeth Hospital Evangelina Elizondo,
Actress, Mexico Christopher Frayling, Professor, Royal College of
Art Celia Hall, Medical Editor, The Daily Telegraph Sandra Horning,
M.D., Past President, American Society of Clinical Oncology (ASCO)
Alison Jones, M.D., Consultant Medical Oncologist, Royal Free
Hospital Geralyn Lucas, Cancer Survivor, Author and Producer,
Lifetime Television Martin Murphy, M.D., Editor in Chief, The
Oncologist Jerry Parsons, Global Art Director, Lilly Oncology on
Canvas (Ex-Officio) Ellen Stovall, President and CEO, National
Coalition for Cancer Survivorship (NCCS) Thomas Stuttaford, M.D.,
Health Columnist, The Times Maria Valerio, Journalist, El Mundo
Nicole Zernik, Presidente, Europa Donna, France Lilly Oncology, a
Division of Eli Lilly and Company For more than four decades, Lilly
Oncology has been collaborating with cancer researchers to deliver
innovative treatment choices and valuable programs to patients and
physicians worldwide. Inspired by the courageous patients living
with cancer, Lilly Oncology is providing treatments that are
considered global standards of care and developing a broad
portfolio of novel targeted therapies to accelerate the pace and
progress of cancer care. About Eli Lilly and Company Lilly, a
leading innovation-driven corporation, is developing a growing
portfolio of first-in-class and best-in-class pharmaceutical
products by applying the latest research from its own worldwide
laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides
answers -- through medicines and information -- for some of the
world's most urgent medical needs. Prepared September 2006, M1017
O-LLY (Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO
http://www.newscom.com/cgi-bin/prnh/20041202/OOCLOGO )
http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO
http://www.newscom.com/cgi-bin/prnh/20041202/OOCLOGO DATASOURCE:
Eli Lilly and Company CONTACT: Christine Van Marter of Eli Lilly
and Company, Tel: +1-317-651-1473, Email:
Copyright